| Antigen | A 22 amino acid peptide sequence (gene accession # 015350) (designated P73A12-P, control peptide) mapping at the C-terminus of human p73¿ (1) was used to generate anti-human p73¿. The peptide was coupled with KLH |
| Form | Antiserum Unpurified |
| Product Type | Primary Antibodies |
| SpCrossreactivity | P73A12-P is 100% conserved in monkey, 86% in mouse, and 54% in non-mammalian p73 from Barbus barbus. It has no significant homology with p53. Antibody crossreactivity in various species is not established |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |